Yifan Xinfu Pharmaceutical Co Ltd (002019) — Capital Reinvestment Ratio
Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Capital Reinvestment Ratio of 4.60x as of September 2025, meaning it reinvests 5% of its operating cash flow (CN¥40.18 Million) in capital expenditures (CN¥184.68 Million). See how leveraged is Yifan Xinfu Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Yifan Xinfu Pharmaceutical Co Ltd Capital Reinvestment Ratio (2003–2025)
This chart tracks Yifan Xinfu Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 21 annual periods. Check Yifan Xinfu Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
Year-by-year Capital Reinvestment Ratio for Yifan Xinfu Pharmaceutical Co Ltd from 2003 to 2025. For live market cap and broader valuation context, see market value of Yifan Xinfu Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.22x | CN¥458.37 Million | CN¥559.23 Million | ▲ +24.4% |
| 2024 | 0.98x | CN¥640.73 Million | CN¥628.16 Million | ▼ -32.2% |
| 2023 | 1.45x | CN¥348.58 Million | CN¥504.09 Million | ▲ +25.9% |
| 2022 | 1.15x | CN¥472.07 Million | CN¥542.27 Million | ▼ -39.5% |
| 2021 | 1.90x | CN¥301.23 Million | CN¥571.74 Million | ▲ +194.0% |
| 2020 | 0.65x | CN¥1.11 Billion | CN¥715.71 Million | ▼ -30.1% |
| 2019 | 0.92x | CN¥937.24 Million | CN¥866.07 Million | ▲ +48.4% |
| 2018 | 0.62x | CN¥1.17 Billion | CN¥729.21 Million | ▲ +45.2% |
| 2017 | 0.43x | CN¥1.13 Billion | CN¥485.86 Million | ▲ +27.7% |
| 2016 | 0.34x | CN¥855.85 Million | CN¥287.50 Million | ▼ -37.8% |
| 2015 | 0.54x | CN¥401.96 Million | CN¥217.15 Million | ▼ -15.7% |
| 2014 | 0.64x | CN¥139.74 Million | CN¥89.51 Million | ▼ -70.3% |
| 2013 | 2.15x | CN¥34.32 Million | CN¥73.95 Million | ▼ -4.8% |
| 2012 | 2.26x | CN¥29.88 Million | CN¥67.64 Million | ▼ -12.3% |
| 2009 | 2.58x | CN¥58.61 Million | CN¥151.27 Million | ▲ +75.6% |
| 2008 | 1.47x | CN¥83.31 Million | CN¥122.46 Million | ▲ +112.5% |
| 2007 | 0.69x | CN¥248.71 Million | CN¥172.06 Million | ▼ -60.8% |
| 2006 | 1.77x | CN¥32.62 Million | CN¥57.62 Million | ▼ -27.3% |
| 2005 | 2.43x | CN¥24.12 Million | CN¥58.63 Million | ▲ +16.4% |
| 2004 | 2.09x | CN¥33.59 Million | CN¥70.14 Million | ▼ -49.6% |
| 2003 | 4.14x | CN¥12.65 Million | CN¥52.44 Million | — |